Skip to main content
Equibles

NNOX · Nano-X Imaging Ltd. · Metrics

Track NNOX — free

Use NNOX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NNOX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.39 +0.00 (+0.52%)
Rebalance outlook locked
Market Cap
$30.25M
Shares
78.59M
Volume · Oct 22 187.12K Avg daily vol (3M) 1.15M

NNOX metrics

68 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.38
Market cap
$30.25M

Price action

20 metrics
Price change (1W)
-24.6%
Price change (30D)
-47.4%
Price change (3M)
-60.7%
Price change (6M)
-80.8%
Price change (YTD)
-86.3%
Price change (1Y)
-90.6%
Trailing year
Price change (5Y)
-98.4%
52-week high
$4.55
52-week low
$0.38
Change from 52-week high
-91.5%
Change from 52-week low
+0.0%
Annualized volatility
99.1%
Annualized volatility (3M)
88.7%
Beta
1.5
RSI (14D)
20.7
Price vs SMA 50
-46.4%
Price vs SMA 200
-77.2%
Avg volume (3M)
1.15M
Relative volume
0.8
Average dollar volume
$914,862

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
78.59M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.9×
reciprocal yield 51.7%
P / book
0.4
reciprocal yield 239.6%
FCF yield
-172.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-386.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-09-09

Profitability

9 metrics
Gross margin
-337.5%
Operating margin
-765.6%
Trailing 12 months
Net margin
-747.2%
Gross profit (TTM)
−$52.76M
Operating profit (TTM)
−$119.69M
Net income (TTM)
−$116.81M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-333.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.01

Growth

11 metrics
Revenue growth YoY
+36.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$15.63M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+9.4%
Year over year · more shares
Revenue CAGR (3Y)
+14.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-161.2%
Return on assets
-128.1%
Debt / equity
—
Current ratio
2.8
EBITDA (TTM)
—
Free cash flow (TTM)
−$52.09M
Quick ratio
2.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$31.02M
Total assets
$91.19M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$46.70M
Capital expenditures (TTM)
$5.39M
R&D (TTM)
$18.93M
SG&A (TTM)
—
Stock compensation (TTM)
$3.62M
R&D / revenue
121.1%
Stock compensation / revenue
23.2%

Ownership (13F)

9 metrics
13F filers
101
13F filer change QoQ
-27
Institutional ownership
12.8%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-23.5%
Holder tenure
13.5
Price vs estimated holder cost
-76.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.7%

Short interest

3 metrics
Short interest
8.0%
Latest settlement · 7.0 days to cover
Days to cover
7.0d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
$190,656
Insider-sentiment score
91 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1795251 CUSIP M70700105 13F (30d) 13 filings 10 filers Visit website Investor relations